Advertisement
RNTX vs SMMT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNTX is a Buy and SMMT is a Hold.
RNTX's RSI Indicator is remaining in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where RNTX advanced for three days, in 171 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
RNTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RNTX as a result. In 84 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for RNTX turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 35 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
RNTX moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RNTX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. RNTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.034) is normal, around the industry mean (2.978). P/E Ratio (-0.354) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SMMT's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for SMMT moved out of overbought territory on September 15, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 29 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMMT as a result. In 86 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for SMMT turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 41 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
SMMT moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMMT advanced for three days, in 244 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
SMMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 126 of 149 cases where SMMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. SMMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMMT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.375) is normal, around the industry mean (3.009). P/E Ratio (-14.495) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
RNTX | SMMT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 93 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 70 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 50 | 63 | |
P/E GROWTH RATING 1..100 | 15 | 63 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RNTX's Valuation (74) in the null industry is in the same range as SMMT (91) in the Biotechnology industry. This means that RNTX’s stock grew similarly to SMMT’s over the last 12 months.
SMMT's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that SMMT’s stock grew similarly to RNTX’s over the last 12 months.
SMMT's SMR Rating (100) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that SMMT’s stock grew similarly to RNTX’s over the last 12 months.
RNTX's Price Growth Rating (50) in the null industry is in the same range as SMMT (63) in the Biotechnology industry. This means that RNTX’s stock grew similarly to SMMT’s over the last 12 months.
RNTX's P/E Growth Rating (15) in the null industry is somewhat better than the same rating for SMMT (63) in the Biotechnology industry. This means that RNTX’s stock grew somewhat faster than SMMT’s over the last 12 months.
| RNTX | SMMT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | 6 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 79% | 1 day ago 90% |
| Momentum ODDS (%) | 2 days ago 85% | 1 day ago 83% |
| MACD ODDS (%) | 2 days ago 90% | 1 day ago 85% |
| TrendWeek ODDS (%) | 2 days ago 89% | 1 day ago 86% |
| TrendMonth ODDS (%) | 2 days ago 90% | 1 day ago 86% |
| Advances ODDS (%) | 20 days ago 79% | 1 day ago 86% |
| Declines ODDS (%) | 2 days ago 87% | 7 days ago 83% |
| BollingerBands ODDS (%) | 2 days ago 84% | 1 day ago 89% |
| Aroon ODDS (%) | N/A | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RNTX’s FA Score shows that 1 FA rating(s) are green while SMMT’s FA Score has 0 green FA rating(s).
- RNTX’s FA Score: 1 green, 4 red.
- SMMT’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RNTX’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).
- RNTX’s TA Score: 4 bullish, 5 bearish.
- SMMT’s TA Score: 5 bullish, 4 bearish.
Price Growth
RNTX (@Biotechnology) experienced а -21.14% price change this week, while SMMT (@Biotechnology) price change was +3.67% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.
Reported Earning Dates
RNTX is expected to report earnings on Nov 06, 2026.
SMMT is expected to report earnings on Mar 18, 2027.
Industries' Descriptions
@Biotechnology (-0.45% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
RNTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, RNTX has been loosely correlated with PRLD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RNTX jumps, then PRLD could also see price increases.
| Ticker / NAME | Correlation To RNTX | 1D Price Change % | ||
|---|---|---|---|---|
| RNTX | 100% | +7.81% | ||
| PRLD - RNTX | 35% Loosely correlated | +4.13% | ||
| RXRX - RNTX | 33% Loosely correlated | +1.39% | ||
| SMMT - RNTX | 31% Poorly correlated | +3.34% | ||
| BMEA - RNTX | 31% Poorly correlated | -11.96% | ||
| VYGR - RNTX | 30% Poorly correlated | +6.83% | ||
More | ||||